期刊文献+

胸腺瘤中β5t、p63和CD20的表达及其意义 被引量:5

Expression and significance of β5t,p63 and CD20 in thymoma
下载PDF
导出
摘要 目的 探讨β5t、p63和CD20在胸腺瘤中的表达及其意义。方法 观察34例胸腺瘤手术切除标本的组织学形态,采用免疫组化EnVision法检测β5t、p63和CD20在胸腺瘤中的表达,并复习相关文献。结果 (1)β5t在A型胸腺瘤中上皮细胞呈胞质并核旁点状加强阳性(4/4);在B型胸腺瘤中呈核质阳性(20/20),其中在B1型强阳性(10/10),B2型中等阳性(4/6)、弱阳性(2/6),B3中等阳性(1/2)、弱阳性(1/2),在B1型与B2、B3型中阳性强度呈逐渐下降趋势(P〈0.001);在AB型胸腺瘤中呈上述两种形态(9/9)。(2)p63在胸腺瘤上皮细胞中阳性率为60%~100%,在A型胸腺瘤中呈大片状分布(4/4),在B1、B2、B3型胸腺瘤中分别呈散在分布(10/10)、簇状或小片状分布(6/6)、大片状分布(2/2)。(3)CD20在A和AB型胸腺瘤上皮中呈局灶阳性(4/4、8/9),在B型胸腺瘤中呈阴性。结论 β5t、p63和CD20三者联合检测可以更好地对胸腺瘤进行分型,且β5t与p63相对应可有助于对B型胸腺瘤进行分型。 Purpose To study the expression of 155t, p63 and CD20 and their significance in thymoma. Methods The microscopic and immunohistochemical EnVision features were examined in 34 cases of thymoma, with review of related literatures. Results ( 1 ) 155t was expressed in the cytoplasm of neoplastic epithelial cells with paranuclear dotted expression in type A thymoma (4/4). 155t was expressed in the cytoplasm and nulcear of neoplastic epithelial cells of type B thymoma (20/20). Among the subtypes of thymoma, de- gree of expression of 155t was expressed was (+++) in type B1 ( 10/10), (++) in type B2 (4/6), ( + ) in type B2 (2/6), and (++) (1/2) in type B3. Degree of expression of 155t was declined from type B1 to B2, B3 (P 〈 0. 001 ). In type AB thymoma shows two pat- terns as in above. (2) Positive rate of p63 in thymoma was 60% ~ 100%. 1363 was expressed in large sheet in type A thymoma, scat- tered distubution in type B1, cluster or small sheet in type B2, and large sheet in type B3. (3) The experssion of CD20 was focal posi- tive in type A and AB thymoma (4/4, 8/9) and was negative in type B. Conclusion The combined expression of 155t, p63 and CD20 could be better to classification of thymoma. 155t and p63 may be better helpful for the classification of type B thymoma.
出处 《临床与实验病理学杂志》 CAS CSCD 北大核心 2016年第3期292-296,共5页 Chinese Journal of Clinical and Experimental Pathology
关键词 胸腺瘤 β5t P63 CD20 免疫组织化学 thymoma 135t p63 CD20 immunohistochemistry
  • 相关文献

参考文献20

  • 1Duwe B V, Sterman D H, Musani A I. Tumors of the mediastinum [J]. Chest, 2005,128(4) :2893 -909.
  • 2Travis W D, Brambilla E, Muller-Hermelink H K, et al. World Heahh Organization classification of tumours. Pathology and genet- ics of tumors of the lung, pleura, thymus and heart [ M ]. Lyon : IARC Press, 2004 : 167 - 92.
  • 3Travis W D, Brambilla E, Burke A P, et al. WHO classification of tumours of the lung, pleura, thymus and heart [ M ]. Lyon : IARC Press, 2015 : 183 - 203.
  • 4Marx A, Strfibel P, Badve S S, et al. ITMIG consensus statementon the use of the WHO histological classification of thymoma and thymic carcinoma : refined definitions, histological criteria, and reporting [ J ]. J Thorac Oncol, 2014,9 ( 5 ) :596 - 611.
  • 5Murata S, Sasaki K, Kishimotu T, et al. Regulation of CD8 + T cell development by thymus-specific proteasomes [ J ]. Science, 2007,316 : 1349 - 53.
  • 6Ripen A M, Nitta T, Murata S, et al. Ontogeny of thymic cortical epithelial cells expressing the thymoproteasome subunit b5t [ J]. Eur J Immunol, 2011,41:1278 -87.
  • 7Yamada Y, Tomaru U, Ishizu A, et al. Expression of protesome subunit 135t in thymic epithelial tumors [ J ]. Am J Surg Pathol, 2011,35 (9) :1296 -304.
  • 8Tomaru U, Yamada Y, Ishizu A, et al. Proteasome subunit 135t expression in cervical ectopic thymoma[ J]. J Clin Pathol, 2012, 65(9) :858 -9.
  • 9Yamada Y, Tomaru U, Ishizu A, et al. Expression of thymopro- teasome subunit 135t in type AB thymoma [ J ]. J Clin Pathol, 2014,67(3) :276 -8.
  • 10Yang A, Kaghad M, Wang Y, et al. p63, p53 homolog at 3q27- 29, encodes multiple products with transactivating, death-indu- cing, and dominant-negative activities [ J ]. Mol Cell, 1998,2 (3) :305 - 16.

二级参考文献20

  • 1Harris NL,Muller-Hermelink HK.Thymoma classification:a siren's song of simplicity.Am J Clin Pathol,1999,112(3):299-303.
  • 2Shimosato Y.Controversies surrounding the subclassification of thymoma.Cancer,1994,74(2):542-544.
  • 3Muller-Hermelink HK,Engel P,Kuo TT,et al.Tumours of the thymus//Travis WD,Brambilla E,Muller-Hermelink HK,et al.World Health Organization classification of tumours.Tumours of the lung,pleura,thymus,and heart.Lyon:IARC Press,2004:146-171.
  • 4Moran CA,Suster S.The World Health Organization (WHO)histologic classifycation of thymomas:a reanalysis.Curr Treat Options Oncol,2008,9(4-6):288-299.
  • 5Azad NS,Ahmad Z,Ahsan A,et al.Thymoma:a clinicopathologic association of world health organization histologic subtype and invasive behaviour.J Coll Physicians Surg Pak,2007,17 (11):659-661.
  • 6Alexiev BA,Drachenberg CB,Burke AP.Thymomas:a cytological and immuno-histochemical study,with emphasis on lymphoid and neuroendocrine markers.Diagn Patho1,2007,2:13.
  • 7Chilosi M,Castelli P,Martignoni G,et al.Neoplastic epithelial cells in a subset of human thymomas express the B cell-associated CD20 antigen.Am J Surg Pathol,1992,16(10):988-997.
  • 8Nakajima J,Takamoto S,Oka T,et al.Flow cytometric analysis of lymphoid cells in thymic epithelial neoplasms.Eur J Cardiothorac Surg,2000,18 (3):287-292.
  • 9Fang D,Nguyen TK,Leishear K,et al.A Tumorigenic subpopulation with stem cell properties in melanomas.Cancer Res,2005,65(20):9328-9337.
  • 10Pan CC,Chen WY,Chiang H.Spindle cell and mixed spindle/lymphocytic thymomas:an integrated clinicopathologic and immunohistochemical study of 81 cases.Am J Surg Pathol,2001,25(1):111-120.

同被引文献28

引证文献5

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部